Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma

Frontiers in Immunology

Volumn 4, Issue FRB, 2013, Pages

  Dumitru, Claudia A ^a   Bankfalvi, Agnes ^a   Gu, Xiang ^a   Eberhardt, Wilfried E ^a   Zeidler, Reinhard ^b   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer related inflammation; Clinical outcome; Head and neck cancer; Tumor microenvironment; Tumor migration

Indexed keywords

CORTACTIN;

ARTICLE; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; OROPHARYNX CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

EID: 84883735654     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00033     Document Type: Article

References (28)

1. Ammer, A. G., and Weed, S. A. (2008). Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil. Cytoskeleton 65, 687-707.
2. Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., et al. (2011). Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am. J. Pathol. 179, 1455-1470.
3. Cai, J. H., Zhao, R., Zhu, J. W., Jin, X. L., Wan, F. J., Liu, K., et al. (2010). Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J. Gastrointest. Surg. 14, 1248-1257.
4. Choong, N., and Vokes, E. (2008). Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J. Clin. 58, 32-53.
5. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867.
6. Donskov, F., and von der Maase, H. (2006). Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J. Clin. Oncol. 24, 1997-2005.
7. Dumitru, C. A., Fechner, M. K., Hoffmann, T. K., Lang, S., and Brandau, S. (2012a). A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J. Leukoc. Biol. 91, 591-598.
8. Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., and Brandau, S. (2012b). Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 61, 1155-1167.
9. Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., et al. (2011). Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int. J. Cancer 129, 859-869.
10. Gibcus, J. H., Mastik, M. F., Menkema, L., de Bock, G. H., Kluin, P. M., Schuuring, E., et al. (2008). Cortactin expression predicts poor survival in laryngeal carcinoma. Br. J. Cancer 98, 950-955.
11. Gregory, A. D., and Houghton, A. M. (2011). Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 71, 2411-2416.
12. Hofman, P., Butori, C., Havet, K., Hofman, V., Selva, E., Guevara, N., et al. (2008). Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br. J. Cancer 98, 956-964.
13. Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coelle, C., Mouroux, J., et al. (2012). Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 118, 1726-1737.
14. Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., and Weiss, S. (2010). Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 120, 1151-1164.
15. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M. J. (2007). Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66.
16. Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., and von der Maase, H. (2009). Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709-4717.
17. Jensen, T. O., Schmidt, H., Moller, H. J., Donskov, F., Hoyer, M., Sjoegren, P., et al. (2012). Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 118, 2476-2485.
18. Kuang, D. M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., et al. (2011). Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 54, 948-955.
19. Li, X., Zheng, H., Hara, T., Takahashi, H., Masuda, S., Wang, Z., et al. (2008). Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int. J. Oncol. 33, 69-79.
20. Lin, W. W., and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183.
21. Nozawa, H., Chiu, C., and Hanahan, D. (2006). Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 103, 12493-12498.
22. Rauch, J., Ahlemann, M., Schaffrik, M., Mack, B., Ertongur, S., Andratschke, M., et al. (2004). Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem. Biophys. Res. Commun. 323, 156-162.
23. Rodrigo, J. P., Garcia-Carracedo, D., Garcia, L. A., Menendez, S., Allonca, E., Gonzalez, M. V., et al. (2009). Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J. Pathol. 217, 516-523.
24. Strell, C., Lang, K., Niggemann, B., Zaenker, K. S., and Entschladen, F. (2010). Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Exp. Cell Res. 316, 138-148.
25. Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., et al. (2011). Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 129, 2183-2193.
26. Wang, G. C., Hsieh, P. S., Hsu, H. H., Sun, G. H., Nieh, S., Yu, C. P., et al. (2009). Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness. World J. Urol. 27, 557-563.
27. Wu, Y., Zhao, Q., Peng, C., Sun, L., Li, X. F., and Kuang, D. M. (2011). Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J. Pathol. 225, 438-447.
28. Xu, X. Z., Garcia, M. V., Li, T. Y., Khor, L. Y., Gajapathy, R. S., Spittle, C., et al. (2010). Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod. Pathol. 23, 187-196.